chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 12.0
Sex: M
Vaccine: MEN
Symptoms: No adverse event, Product storage error
Clinical narrative: temperature excursion of menquadfi; max/low temperature reached: 46.7F Duration out of labelled range: 8 days with no reported adverse event; temperature excursion of menquadfi vaccine administered with no reported adverse event; Initial information received on 03-Feb-2025 regarding an unsolicited valid non-serious case received from a other health professional.  This case was linked to US-SA-2025SA035119, US-SA-2025SA035116, US-SA-2025SA035137 and US-SA-2025SA035178.  This case involves a 12 years old male patient who was administered with Meningococcal A-C-Y-W135 (T Conj) Vaccine [Menquadfi] after excursion, with no reported adverse event and the vaccine were exposed to temperature excursion of; max/low temperature reached: 46.7f duration out of labelled range: 8 days, with no reported adverse event.   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received (0.5 ml, once) dose of suspect Meningococcal A-C-Y-W135 (T Conj) Vaccine, Solution for injection (strength: standard, frequency: once) (lot: U8370AA, Expiry date: 30-apr-2028) via unknown route in unknown administration site for prophylactic vaccination (immunization).  On an unknown date the Meningococcal A-C-Y-W135 (T Conj) Vaccine was exposed to temperature excursion of max/low temperature reached: 46.7 f duration out of labelled range: 8 days with no reported adverse event (product storage error) and was administered to a patient with no reported adverse event (poor quality product administered) (latency: same day) following the administration of Meningococcal A-C-Y-W135 (T Conj) Vaccine.  Human error: yes  Action taken : not applicable.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments:  US-SA-2025SA035116: US-SA-2025SA035137: US-SA-2025SA035119: US-SA-2025SA035178:
Age: 16.0
Sex: F
Vaccine: MENB
Symptoms: Erythema, Feeling hot, Peripheral swelling
Clinical narrative: arm swelling, redness, warmth started 24 hrs after injection.  she also received a flu vaccine in the same arm
Age: 79.0
Sex: M
Vaccine: VARZOS
Symptoms: Muscular weakness, Pain
Clinical narrative: Muscle weakness, pain,
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Died 3 months later 12/28/22
Age: 28.0
Sex: M
Vaccine: COVID19, FLU3, IPV
Symptoms: Pallor, Syncope, Unresponsive to stimuli
Clinical narrative: Patient received 3 immunizations (Polio, COVID, Flu). After receiving immunization, patient was leaving with other family member and fainted. Patients parent was able to catch the patient before hitting the ground. Able to take the patient back into the Immunization booth where patient was assessed. Code White was called within pharmacy, followed immediately by EMS as patient was very pale and not responding right away.  Patient was sat on the floor with feet elevated. Pharmacist stayed with Patient, as well as management from pharmacy to assist with the event. Upon questioning the patient, patient had just recently given/had blood drawn prior to immunization, suffers from low blood pressure (per mother), as well as only had 1 slice of bread; all of which may have contributed to the adverse event. Paramedics came to pharmacy to assess patient. Patient felt much better by time paramedics came. Denied transport to hospital. Patient left pharmacy on their own free will with no help needed. Patient's parents was the driver.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, FLU3, MMRV
Symptoms: Injection site erythema, Injection site swelling, Pyrexia
Clinical narrative: 3-4 hours later developed 103 fever and redness and swelling of L deltoid on 4/3. Examined in office 4/5, afebrile since the one fever but erythema still present. Non tender. No discharge. Not concerning for cellulitis, supportive care with compress, Motrin/tylenol. Used skin marker to outline border to asses for any worsening.
Age: 15.0
Sex: F
Vaccine: HPV9
Symptoms: Biopsy cervix abnormal, Cervical dysplasia, Colposcopy abnormal, Human papilloma virus test positive, Papilloma viral infection
Clinical narrative: In December of 2024 I had an abnormal Pap smear, showing positive for HPV. I then went and had a colposcopy where they biopsied three different abnormalities they saw. It came back as pre-cancerous cells, one a CIN-1, and the other two CIN 2-3's. I now will be going in early March for a LEEP procedure to remove the cells, hopefully eradicating the HPV and the "pre-cancer". The LEEP procedure will put me at a higher chance of having a high-risk pregnancy in the future. I also will have more frequent Pap smears in the future to insure the HPV & "pre-cancer" are gone and stay gone.
Age: 15.0
Sex: F
Vaccine: HPV9
Symptoms: Smear cervix abnormal
Clinical narrative: In December of 2024 I had an abnormal Pap smear, showing positive for HPV. I then went and had a colposcopy where they biopsied three different abnormalities they saw. It came back as pre-cancerous cells, one a CIN-1, and the other two CIN 2-3's. I now will be going in early March for a LEEP procedure to remove the cells, hopefully eradicating the HPV and the "pre-cancer". The LEEP procedure will put me at a higher chance of having a high-risk pregnancy in the future. I also will have more frequent Pap smears in the future to insure the HPV & "pre-cancer" are gone and stay gone.
Age: 12.0
Sex: F
Vaccine: HPV9
Symptoms: Product storage error
Clinical narrative: Patient was given vaccien post temperature excursion prior to vaccine being properly cleared by vaccine coordinator with manufactures.  Vaccines have successfully been cleared with manufacture and were cleared for patient use.
Age: 40.0
Sex: F
Vaccine: RSV
Symptoms: Exposure during pregnancy, Inappropriate schedule of product administration
Clinical narrative: Patient is currently 34 weeks pregnant which falls under the window for RSV but due to policy changes, pharmacy was no longer eligible to give the patient the vaccine.
Age: 12.0
Sex: F
Vaccine: MNQ
Symptoms: Product storage error
Clinical narrative: Patient was given vaccien post temperature excursion prior to vaccine being properly cleared by vaccine coordinator with manufactures. Vaccines have successfully been cleared with manufacture and were cleared for patient use.
Age: 64.0
Sex: F
Vaccine: RSV
Symptoms: Extra dose administered, No adverse event
Clinical narrative: patient came to pharmacy and asked for RSV vaccine because her doctor wanted to receive it since cases are high , we processed it and insurance covered it . ( she received the vaccine on 12/17/24) , she came to pharmacy today (2/5/25) and asked for immunization history report once I printed out I noticed she received  this vaccine two times. I asked her if she experienced any side effects  and she mentioned she did not have any .  she is aware of this situation fully.
Age: 15.0
Sex: M
Vaccine: HPV9, TDAP
Symptoms: Product storage error
Clinical narrative: Patient was given vaccien post temperature excursion prior to vaccine being properly cleared by vaccine coordinator with manufactures. Vaccines have successfully been cleared with manufacture and were cleared for patient use.
Age: 0.75
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: 9mo was given diluted 5-11 yo dosage of pfizer covid vaccine. Given at approximately 9am. At 6pm no known adverse events to patient.
Age: 16.0
Sex: M
Vaccine: HPV9, MNQ
Symptoms: Product storage error
Clinical narrative: Patient was given vaccien post temperature excursion prior to vaccine being properly cleared by vaccine coordinator with manufactures. Vaccines have successfully been cleared with manufacture and were cleared for patient use.
Age: 92.0
Sex: M
Vaccine: RSV
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Patient was vaccinated twice (12/2023 and 2/2025) when there is only one dose in series at this time. No adverse reactions to record at time of submission of this report.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Condition aggravated, Dyspnoea exertional, Fatigue, Pericarditis
Clinical narrative: Pericarditis resulting in long-standing chronic fatigue & dyspnea on exertion.
Age: 34.0
Sex: F
Vaccine: TDAP
Symptoms: Product storage error
Clinical narrative: Patient was given vaccine post temperature excursion prior to vaccine being properly cleared by vaccine coordinator with manufactures. Vaccines have successfully been cleared with manufacture and were cleared for patient use.
Age: 87.0
Sex: F
Vaccine: RSV
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Patient was vaccinated twice (12/2023 and 2/2025) when there is only one dose in series at this time. No adverse reactions to record at time of submission of this report.
Age: 84.0
Sex: M
Vaccine: RSV
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Patient received RSV on 10/10/2023;   Software and ins did not catch duplication; Patient did not recall he had in October of 2023 as well and requested vaccine.  I called patient on 2/5/2025 to follow up with his well being and he reported no SE or reaction from 2nd shot.
Age: 82.0
Sex: F
Vaccine: RSV
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Patient received RSV in October 2023.  Software and agency did not recall she had RSV in October of 2023 and requested vaccine.  I called patient on 2/5/2025 to follow up with her well being and she reported no SE or reaction from 2nd shot.
Age: 67.0
Sex: F
Vaccine: RSV
Symptoms: Cyanosis, Erythema, Inflammation, Limb injury, Nodule
Clinical narrative: Patient arm turned red + blue + inflamed and knotted initially did not get any better with time so sought help from her primary care MD who prescribed her an oral + topical antibiotic her imz was 1/8/25 - she presented to us today 2-4-25 - she says treated w smaller that is smaller than it was initially - it scabbed over and is red around it and swollen in a little. She did hit the area with her refrigerator handle - she has a follow up appt with her MD on Tues 2-11-25
Age: 67.0
Sex: F
Vaccine: RSV
Symptoms: Peripheral swelling, Scab
Clinical narrative: Patient arm turned red + blue + inflamed and knotted initially did not get any better with time so sought help from her primary care MD who prescribed her an oral + topical antibiotic her imz was 1/8/25 - she presented to us today 2-4-25 - she says treated w smaller that is smaller than it was initially - it scabbed over and is red around it and swollen in a little. She did hit the area with her refrigerator handle - she has a follow up appt with her MD on Tues 2-11-25
Age: 1.0
Sex: F
Vaccine: DTPPVHBHPB, MMR, VARCEL, DTPPVHBHPB, MMR, PNC13, VARCEL, MMR, VARCEL
Symptoms: Decreased appetite, Extra dose administered, Inappropriate schedule of product administration, Injection site rash, Irritability
Clinical narrative: the parents reported the patient having a fever after vaccinations were given; This spontaneous report has been received from Other Health Professional referring a 1-year-old female patient.   The patient's pertinent medical history, previous drug reactions or allergies and concomitant therapies were not reported.  On an unknown date in August 2024, the patient was vaccinated with the initial doses of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection, and  varicella virus vaccine live (oka/merck) (VARIVAX) injection, both vaccines were administered at a dose of 0.5 milliliter, intramuscularly (IM) for immunisation (strength, anatomical location of administration, lot #, and expiration were not provided regarding any of the vaccines). On 31-JAN-2025, she was vaccinated with the second doses of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection, rHA, administered at a dose of 0.5 mL, IM, for immunisation (strength, and anatomical location of administration were not provided; lot # reported as Y004117, which has been determined to be a valid lot # for this vaccine, expiration provided and validated to be on 12-FEB-2026); and varicella virus vaccine live (oka/merck) (VARIVAX) injection, at a dose of 0.5 mL, administered IM, also for immunisation (strength, and anatomical location of administration were not provided; lot # reported as Y013305, which has been determined to be an invalid lot # for this vaccine, expiration provided as 02-AUG-2026).  On 05-FEB-2025, the parents reported the patient having a fever on an unknown date in 2025 after vaccinations were given (pyrexia). At the time of this report, the outcome of the event was not provided.   The causal relationship between pyrexia and both suspect vaccines was not provided.
Age: 1.0
Sex: F
Vaccine: DTPPVHBHPB, MMR, VARCEL, DTPPVHBHPB, MMR, PNC13, VARCEL, MMR, VARCEL
Symptoms: Malaise, Pyrexia, Rash, Vomiting
Clinical narrative: the parents reported the patient having a fever after vaccinations were given; This spontaneous report has been received from Other Health Professional referring a 1-year-old female patient.   The patient's pertinent medical history, previous drug reactions or allergies and concomitant therapies were not reported.  On an unknown date in August 2024, the patient was vaccinated with the initial doses of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection, and  varicella virus vaccine live (oka/merck) (VARIVAX) injection, both vaccines were administered at a dose of 0.5 milliliter, intramuscularly (IM) for immunisation (strength, anatomical location of administration, lot #, and expiration were not provided regarding any of the vaccines). On 31-JAN-2025, she was vaccinated with the second doses of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection, rHA, administered at a dose of 0.5 mL, IM, for immunisation (strength, and anatomical location of administration were not provided; lot # reported as Y004117, which has been determined to be a valid lot # for this vaccine, expiration provided and validated to be on 12-FEB-2026); and varicella virus vaccine live (oka/merck) (VARIVAX) injection, at a dose of 0.5 mL, administered IM, also for immunisation (strength, and anatomical location of administration were not provided; lot # reported as Y013305, which has been determined to be an invalid lot # for this vaccine, expiration provided as 02-AUG-2026).  On 05-FEB-2025, the parents reported the patient having a fever on an unknown date in 2025 after vaccinations were given (pyrexia). At the time of this report, the outcome of the event was not provided.   The causal relationship between pyrexia and both suspect vaccines was not provided.
Age: 1.0
Sex: F
Vaccine: DTPPVHBHPB, MMR, VARCEL, DTPPVHBHPB, MMR, PNC13, VARCEL, MMR, VARCEL
Symptoms: Pyrexia
Clinical narrative: the parents reported the patient having a fever after vaccinations were given; This spontaneous report has been received from Other Health Professional referring a 1-year-old female patient.   The patient's pertinent medical history, previous drug reactions or allergies and concomitant therapies were not reported.  On an unknown date in August 2024, the patient was vaccinated with the initial doses of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection, and  varicella virus vaccine live (oka/merck) (VARIVAX) injection, both vaccines were administered at a dose of 0.5 milliliter, intramuscularly (IM) for immunisation (strength, anatomical location of administration, lot #, and expiration were not provided regarding any of the vaccines). On 31-JAN-2025, she was vaccinated with the second doses of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection, rHA, administered at a dose of 0.5 mL, IM, for immunisation (strength, and anatomical location of administration were not provided; lot # reported as Y004117, which has been determined to be a valid lot # for this vaccine, expiration provided and validated to be on 12-FEB-2026); and varicella virus vaccine live (oka/merck) (VARIVAX) injection, at a dose of 0.5 mL, administered IM, also for immunisation (strength, and anatomical location of administration were not provided; lot # reported as Y013305, which has been determined to be an invalid lot # for this vaccine, expiration provided as 02-AUG-2026).  On 05-FEB-2025, the parents reported the patient having a fever on an unknown date in 2025 after vaccinations were given (pyrexia). At the time of this report, the outcome of the event was not provided.   The causal relationship between pyrexia and both suspect vaccines was not provided.
Age: 19.0
Sex: F
Vaccine: MEN
Symptoms: Extra dose administered, No adverse event
Clinical narrative: 19 year old patient who received her MENQUADFI dose mistakenly. She received it 2 1/2 years after her 2nd dose with no reported adverse event; Initial information received on 03-Feb-2025 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 19 years old female patient who received her MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE [MENQUADFI] dose mistakenly she received it 2 1/2 years after her 2nd dose with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 21-Jan-2025, the patient received a dose 3 of suspect MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE dose 0.5 ml 1x(once) Solution for injection (strength standard) lot U8194AA expiry-30-Sep-2027 via intramuscular route in the right deltoid for Immunization mistakenly. she received it 2 1/2 years after her 2nd dose with no reported adverse event (extra dose administered) (latency same day).  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event (19 year old patient who received her MENQUADFI dose mistakenly. She received it 2 1/2 years after her 2nd dose with no reported adverse event).  At time of reporting, the outcome was Unknown for the event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 4.0
Sex: M
Vaccine: MMRV
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse side effects were reported. No additional information available at this time.; HCP called regarding an PROQUAD vaccine that expired 1/14/2025 and was administered to a patient on 2/1/2025; This spontaneous report was received from a medical assistant referring to a 4-year-old male patient. The patient's medical history, historical drugs, past drug reactions or allergies, concurrent conditions, and concomitant drugs were not reported.   On 01-FEB-2025, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (rHA) (PROQUAD) injection (lot#: X019301, expiration date: 14-JAN-2025; strength, dose, and route of administration were not reported) by a healthcare professional for prophylaxis (expired product administered). No adverse event occurred.
Sex: U
Vaccine: HEPA
Symptoms: Expired product administered
Clinical narrative: Expired product administered; This non-serious case was reported by a other health professional via patient support programs and described the occurrence of expired vaccine used in a patient who received HAV (Havrix) for prophylaxis.   On an unknown date, the patient received Havrix. On an unknown date, an unknown time after receiving Havrix, the patient experienced expired vaccine used (Verbatim: Expired product administered). The outcome of the expired vaccine used was unknown.   Additional Information: GSK Receipt Date: 03-FEB-2025 The health care professional reported that a patient received expired dose of Havrix vaccine, which led to expired vaccine used.
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Shingles happened in the 3 year span; Drug dose administration interval too long; This non-serious case was reported by a consumer via call center representative and described the occurrence of shingles in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix and the 1st dose of Shingrix. On an unknown date, not applicable after receiving Shingrix and an unknown time after receiving Shingrix, the patient experienced shingles (Verbatim: Shingles happened in the 3 year span) and drug dose administration interval too long (Verbatim: Drug dose administration interval too long). The outcome of the shingles and drug dose administration interval too long were unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.     It was unknown if the company considered the shingles to be related to Shingrix.   Additional Information: GSK Receipt Date: 09-JAN-2025 Consumer was the reporter. The patient stated that he had his first dose of Shingrix about 3 years ago. The patient recently had his second dose of Shingrix administered late dose. The patient stated that he believed he has a few cases of shingles in those three years lack of effect. All cases of shingles happened in the 3 year span prior to having his second dose of Shingrix administered. The patient received 2nd dose of Shingrix later than the recommended schedule, which led to lengthening of vaccination schedule.
Sex: M
Vaccine: HIBV
Symptoms: Product preparation issue
Clinical narrative: may have administered the diluent only; may have administered the diluent only; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a 2-month-old male patient who received Hib (Hiberix) for prophylaxis.   On an unknown date, the patient received Hiberix. On an unknown date, an unknown time after receiving Hiberix, the patient experienced inappropriate preparation of medication (Verbatim: may have administered the diluent only) and inappropriate dose of vaccine administered (Verbatim: may have administered the diluent only). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 09-JAN-2025 Pharmacist stated that she was contacted by a clinic staff member who was concerned that they may have administered the diluent only portion of Hiberix to a patient within the past 1-2 months. The staff was not sure if this happened and did not know which patient it was, but they narrowed down to 5 patients, of which one of them could have received diluent only. It was possible that the 5 patients may all be given another dose, but at the time of reporting this decision was not made. The reporter did not have the lot number of the product at the time of reporting. The patient received only diluent of Hiberix, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. This case is 1 of the 5 linked cases reported by the same reporter.; Sender's Comments:  US-GSK-US2025002641:Same reporter/Different patient US-GSK-US2025002645:Same reporter/Different Patient US-GSK-US2025002639:Same reporter/Different Patient US-GSK-US2025002647:Same reporter/Different patient
Age: 33.0
Sex: F
Vaccine: HEP
Symptoms: Underdose
Clinical narrative: patient received a dose of a pediatric presentation of Hepatitis B; patient received a dose of a pediatric presentation of Hepatitis B; This non-serious case was reported by a other health professional via call center representative and described the occurrence of underdose in a 33-year-old female patient who received Hepatitis B vaccine (batch number AHBVB340AA) for prophylaxis.   On 21-FEB-2007, the patient received the 3rd dose of Hepatitis B vaccine. On 21-FEB-2007, an unknown time after receiving Hepatitis B vaccine, the patient experienced underdose (Verbatim: patient received a dose of a pediatric presentation of Hepatitis B) and adult use of a child product (Verbatim: patient received a dose of a pediatric presentation of Hepatitis B). The outcome of the underdose and adult use of a child product were unknown.   Additional Information: GSK Receipt Date: 03-FEB-2025 The nurse reported that a patient received a dose of a pediatric presentation of Hepatitis B vaccine, which led to underdose and adult use of a child product. The vaccine administration facility was the same as primary reporter.
Age: 77.0
Sex: F
Vaccine: TDAP
Symptoms: Extra dose administered
Clinical narrative: duplicate vaccine given outside of guidelines
Age: 67.0
Sex: M
Vaccine: TDAP
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Pain
Clinical narrative: right upper arm tenderness, swelling and erythema, body aches and fever 24 hours after vaccine; recommended ice to arm and tylenol/ibuprofen prn for fever and body aches
Age: 0.33
Sex: F
Vaccine: DTAPHEPBIP, HIBV, RV5
Symptoms: Pyrexia
Clinical narrative: patient is having fever of 101.7 within one day of receiving vaccinations as well induration on left thigh. Concern with symptoms due to these not being normal reactions for 4-month immunizations.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Eyelid disorder, Feeling abnormal, Food allergy, Headache
Clinical narrative: Out of the body experience, like  a floating sensation. I could not keep my eyes open, headache, febrile, I could not lift my arms, slept for two days (Lethargy  ) severe sweats and chills. I have memory fog  episodes after this happened.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersomnia, Lethargy, Memory impairment, Mobility decreased, Pyrexia
Clinical narrative: Out of the body experience, like  a floating sensation. I could not keep my eyes open, headache, febrile, I could not lift my arms, slept for two days (Lethargy  ) severe sweats and chills. I have memory fog  episodes after this happened.
Age: 1.25
Sex: M
Vaccine: DTAPIPV
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: The child received an incorrect vaccine for their age. They should have received Dtap and Polio separately. No treatment or adverse reactions occurred following the vaccination.
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Headache, Hypoaesthesia oral, Paraesthesia oral
Clinical narrative: patient reported headache as well as tingling and numb tongue the morning after. Patient called 2/5/25 to report tingling/numb tongue morning after vaccine. Advised patient to call primary care doctor. Called patient 2/6/25 to see how she was doing, she said she called her doctor and her doctor advised her not to get the second shingles vaccine.
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Patient was given a vaccine that was stored improperly and should have been discarded on 1/7/25. Legal gaudrian of pateint will be notified that the state reccomends that patient get revaccinated,
Age: 29.0
Sex: M
Vaccine: MENB, PNC20
Symptoms: Injection site erythema, Injection site pain, Injection site rash, Injection site swelling
Clinical narrative: redness, pain, swelling, rash to left deltoid. Subsided after 6 days.
Age: 11.0
Sex: M
Vaccine: MENB, MNQ
Symptoms: Injection site erythema, Injection site swelling, Pyrexia
Clinical narrative: PT CALLED INTO OFFICE ON 2/6/2025 STATING HIS ARM WAS RED SWOLLEN AND HOT ON VACCINE SITE. HE ALSO HAD A FEVER ALL NIGHT PER MOM.
Age: 68.0
Sex: F
Vaccine: RSV
Symptoms: Mobility decreased, Pain in extremity
Clinical narrative: sore arm 1st day, day 2 patient was unable to use her left arm upon awakening with worsening  pain and immobility
Sex: F
Vaccine: COVID19
Symptoms: Anaphylactic reaction
Clinical narrative: Anaphylaxis recorded in chart. No additional information provided about which vaccine, date of admin, timing of reaction or details pertaining to the reaction.
Age: 1.5
Sex: F
Vaccine: TDAP
Symptoms: Injection site pain, Wrong product administered
Clinical narrative: Patient give wrong vaccine for tetnus. Given Boostrix and it should have been Daptacel. Spoke with mom, only reaction was soreness of the site for a few days. No treatment needed.
Age: 4.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site induration, Injection site pruritus
Clinical narrative: Itchy at first, then hard knot with significantly large red circle at site. Resolved in three days with Benadryl.
Age: 12.0
Sex: M
Vaccine: DTAP
Symptoms: Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: The patient is 12 years old and should have received the TdaP vaccine but instead was given DTaP in error.
Age: 45.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Bell's palsy, Discomfort, Dysarthria, Dysphagia, Eyelid function disorder
Clinical narrative: Patient received MMR II and Varivax on 01/27/2025. Patient reported that on Monday 01/27/2025 around 6:00pm she began to feel  her right upper chin region  becoming rigid, then on  Tuesday 01/28/25 around 5:00PM began to feel numbness to the right side of  her tongue . On Wednesday 1/29/25 upon arising patient reported that she was not         able to close her right eyelid and could not blink and  in the evening around 5pm was having difficulty talking and drinking water. On  Saturday 2/1/2025  patient reported that around 7:00PM she began to feel pressure to front right side of head, back right side of head and right side of neck. Patient went to Clinic on Thursday 01/30/2025,  was evaluated and told she had  Bells Palsy. Patient was prescribed Vitamin B12  tablets and Artificial Tears.  Per patient she also was instructed to massage face and do exercise. At time of  follow up clinic appointment on Tuesday 02/04/2025,  patient reported that she still cannot close her right eye, has numbness to back right side of tongue and in the evenings continues to feel pressure to front right side of head, back  right side of head and right side of neck. Health Center was informed of above,  evaluated patient and  and concurred with PMD diagnoses of Bells Palsy. Dr. informed this nurse that patient needed further medical treatment  as soon as possible to prevent permanent facial paralysis and was recommended to seek  further medical care and treatment for Bells Palsy.  Patient was provided Department of Health Services Hospital List and instructed patient to go immediately to Medical Center or other option Medical Center. This nurse will contacted patient to see if recommendations were followed,  however patient did not answer the phone and a message was left.
Age: 45.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Head discomfort, Hypoaesthesia oral, Muscle rigidity
Clinical narrative: Patient received MMR II and Varivax on 01/27/2025. Patient reported that on Monday 01/27/2025 around 6:00pm she began to feel  her right upper chin region  becoming rigid, then on  Tuesday 01/28/25 around 5:00PM began to feel numbness to the right side of  her tongue . On Wednesday 1/29/25 upon arising patient reported that she was not         able to close her right eyelid and could not blink and  in the evening around 5pm was having difficulty talking and drinking water. On  Saturday 2/1/2025  patient reported that around 7:00PM she began to feel pressure to front right side of head, back right side of head and right side of neck. Patient went to Clinic on Thursday 01/30/2025,  was evaluated and told she had  Bells Palsy. Patient was prescribed Vitamin B12  tablets and Artificial Tears.  Per patient she also was instructed to massage face and do exercise. At time of  follow up clinic appointment on Tuesday 02/04/2025,  patient reported that she still cannot close her right eye, has numbness to back right side of tongue and in the evenings continues to feel pressure to front right side of head, back  right side of head and right side of neck. Health Center was informed of above,  evaluated patient and  and concurred with PMD diagnoses of Bells Palsy. Dr. informed this nurse that patient needed further medical treatment  as soon as possible to prevent permanent facial paralysis and was recommended to seek  further medical care and treatment for Bells Palsy.  Patient was provided Department of Health Services Hospital List and instructed patient to go immediately to Medical Center or other option Medical Center. This nurse will contacted patient to see if recommendations were followed,  however patient did not answer the phone and a message was left.
Age: 14.0
Sex: F
Vaccine: COVID19, HPV9, MNQ
Symptoms: Product preparation error
Clinical narrative: the Menquadfi vaccine was incorrectly diluted using the merck sterile diluent provided for live virus vaccines (Sterile water, diluent lot# 2031279) and administered to patient. Patient was contacted and agreed to re-vaccination
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Alanine aminotransferase increased, Aspartate aminotransferase increased, Autoimmune hepatitis, Blood alkaline phosphatase increased, Blood bilirubin increased
Clinical narrative: autoimmune hepatitis, liver failure
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Hepatic failure
Clinical narrative: autoimmune hepatitis, liver failure
Age: 10.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Accidentally given the wrong age range for the covid vaccine
Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: Extra dose administered, No adverse event
Clinical narrative: No adverse events noted.  Patient was given a 3rd Shingrix vaccination inadvertently.
Age: 36.0
Sex: M
Vaccine: TDAP
Symptoms: Asthenia, Injected limb mobility decreased, Injection site hypersensitivity, Injection site pain, Muscle oedema
Clinical narrative: Paresthesia to left arm, edema to deltoid, hypersensitive pain reaction at injection site, muscle pain from neck to arm, decreased strength to left arm, decreased ROM to left arm, generalized body aches and self reported fever.
Age: 36.0
Sex: M
Vaccine: TDAP
Symptoms: Myalgia, Pain, Paraesthesia, Pyrexia
Clinical narrative: Paresthesia to left arm, edema to deltoid, hypersensitive pain reaction at injection site, muscle pain from neck to arm, decreased strength to left arm, decreased ROM to left arm, generalized body aches and self reported fever.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Fatigue, Headache, Injection site erythema, Injection site induration, Injection site swelling
Clinical narrative: Pain in arm, red in surrounding area, swollen hard in surrounding area. General fatigue, severe headache, general body aches
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Pain, Pain in extremity
Clinical narrative: Pain in arm, red in surrounding area, swollen hard in surrounding area. General fatigue, severe headache, general body aches
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: Electrocardiogram, Electroencephalogram, Epilepsy
Clinical narrative: Patient was diagnosed with Epilepsy after COVID vaccine. No prior history of concern.
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Discontinued product administered
Clinical narrative: State / CDC kept changing the time of when to stop the 23-24 version and start giving the 24-25 version of the vaccine.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose increased
Clinical narrative: Increased blood sugar after the vaccine and blood sugar increase has continued months later.
Age: 17.0
Sex: F
Vaccine: MNQ
Symptoms: Erythema, Pain in extremity, Skin warm, Sleep disorder, Swelling
Clinical narrative: P24 hours later patient reported "very swollen like a very big bump, red, pain on the bump, and very warm also it?s been making my whole arm hurt with some sharp pain, the pain has been waking me up from my sleep, i can?t sleep cause of the pain"
Age: 54.0
Sex: F
Vaccine: RAB
Symptoms: Diarrhoea, Tinnitus
Clinical narrative: c/o diarrhea in afternoon and ringing in ears on and off for about 3 hours.
Age: 6.0
Sex: M
Vaccine: VARCEL
Symptoms: Circumstance or information capable of leading to medication error
Clinical narrative: The patient, was receiving the Varicella Vaccine. Upon the initial administration attempt the patient flinched in a manner that was greater than expected. When the patient flinched, the mother, who was bracing the child was grazed by the sterile needle. This did not become apparent/noticeable as the child was in a heightened emotional state, so a second successful attempt was made in delivering the entirety of the vaccine. After assessing the child the mother brought to the Nurses attention that she had been grazed by the needle. The mother, who received none of the dosage of the vaccine, did not express any complaint or concern at that time. Supervisors were contacted for guidance. No treatment rendered at the time of the visit. Time frame, Administration time 09:50 am February 6th, 2025.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test normal, Death, Electromyogram, Magnetic resonance imaging head, Magnetic resonance imaging spinal
Clinical narrative: developed UMN disease-died within 1  year of onset of symptoms
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Motor neurone disease
Clinical narrative: developed UMN disease-died within 1  year of onset of symptoms
Age: 66.0
Sex: M
Vaccine: VARZOS
Symptoms: Product preparation issue
Clinical narrative: When going to document the shingles vaccine given to patient, I realized he was only given the reconstitute with adjuvant suspension component liquid. He did not receive the compound with it. As of right now patient has had no reactions. NDC: 58160-829-03 Lot: N35N9 EXP: 11/15/26 0.5mL Adjuvant suspension component  Mfd by Glaxosmithline Bio
Age: 33.0
Sex: M
Vaccine: VARCEL
Symptoms: Headache, Injection site erythema, Injection site induration, Injection site pain, Injection site paraesthesia
Clinical narrative: Redness, induration, burning/itching/tingling sensation to injection site associated with headache
Age: 33.0
Sex: M
Vaccine: VARCEL
Symptoms: Injection site pruritus
Clinical narrative: Redness, induration, burning/itching/tingling sensation to injection site associated with headache
Age: 16.0
Sex: F
Vaccine: MMRV
Symptoms: Extra dose administered, No adverse event
Clinical narrative: A MMRV was given inadvertently. MMR was intended but MMRV was given  along with  Varicella vaccination. Dr. was notified of error via phone.  Mother of child was notified via phone of error. Education was provided to parent of side effects that may occur ie: chicken pox rash, fever 2-3 weeks after vaccine. Mother stated she understood and has thermometer to monitor for increased temperatures, will also monitor for rashes. Will go to local urgent care if need arises. No ill effects have been reported by child's parents at this time. Health Commissioner, Medical Director and direct supervisors were updated.
Age: 0.5
Sex: M
Vaccine: DTAPHEPBIP, PNC20
Symptoms: Hypersensitivity
Clinical narrative: Patient had an allergic reaction to the vaccines given.
Age: 62.0
Sex: F
Vaccine: PNC21
Symptoms: Erythema, Fatigue, Lymphadenopathy, Nasopharyngitis, Rash
Clinical narrative: pt says later in the day after getting the vaccine, she noticed her lymph nodes were swollen and that under the right side of under the jawbone it was red, swollen and hot to the touch.  She had a red raised itchy sore rash on her throat. She used lotion on it and it went away after about four days.  She went to Dr in her primacy doctors clinic on 1/30/2025 with cold symptoms where she was ordered an ultrasound. Results were normal. She was instructed to contact her PCP if her lymph nodes did not go back to normal or continued to enlarge. She continues to remain very tired and still has cold symptoms.
Age: 62.0
Sex: F
Vaccine: PNC21
Symptoms: Rash erythematous, Rash papular, Rash pruritic, Skin warm, Swelling
Clinical narrative: pt says later in the day after getting the vaccine, she noticed her lymph nodes were swollen and that under the right side of under the jawbone it was red, swollen and hot to the touch.  She had a red raised itchy sore rash on her throat. She used lotion on it and it went away after about four days.  She went to Dr in her primacy doctors clinic on 1/30/2025 with cold symptoms where she was ordered an ultrasound. Results were normal. She was instructed to contact her PCP if her lymph nodes did not go back to normal or continued to enlarge. She continues to remain very tired and still has cold symptoms.
Age: 62.0
Sex: F
Vaccine: PNC21
Symptoms: Ultrasound scan
Clinical narrative: pt says later in the day after getting the vaccine, she noticed her lymph nodes were swollen and that under the right side of under the jawbone it was red, swollen and hot to the touch.  She had a red raised itchy sore rash on her throat. She used lotion on it and it went away after about four days.  She went to Dr in her primacy doctors clinic on 1/30/2025 with cold symptoms where she was ordered an ultrasound. Results were normal. She was instructed to contact her PCP if her lymph nodes did not go back to normal or continued to enlarge. She continues to remain very tired and still has cold symptoms.
Age: 18.0
Sex: M
Vaccine: HEPA
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Pt has administered Adult dose of 1mL instead of 0.5mL pediatric dose. Error reported to state who recommended completing VAERS report. Spoke to patient's parent/guardian and no adverse events to report.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Brain fog, Cardiac stress test, Chest pain, Clumsiness
Clinical narrative: First night of secound dose. What light headed, disoriented. Walking into walls. Severely thirsty and nothing Quenched my thirst. Muscle spasms . Then after that migraines , brain fog . Then heart palpitations and sharp chest pain if tried exercise. Then upper outter leg pain . Both legs crying walking up steps . Then stomach issues and was hard to swallow water. Energy levels weee zero and couldn?t think even.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Colonoscopy, Crying, Disorientation, Dizziness, Dysphagia
Clinical narrative: First night of secound dose. What light headed, disoriented. Walking into walls. Severely thirsty and nothing Quenched my thirst. Muscle spasms . Then after that migraines , brain fog . Then heart palpitations and sharp chest pain if tried exercise. Then upper outter leg pain . Both legs crying walking up steps . Then stomach issues and was hard to swallow water. Energy levels weee zero and couldn?t think even.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Gastrointestinal disorder, Imaging procedure, Magnetic resonance imaging head, Mental impairment, Migraine
Clinical narrative: First night of secound dose. What light headed, disoriented. Walking into walls. Severely thirsty and nothing Quenched my thirst. Muscle spasms . Then after that migraines , brain fog . Then heart palpitations and sharp chest pain if tried exercise. Then upper outter leg pain . Both legs crying walking up steps . Then stomach issues and was hard to swallow water. Energy levels weee zero and couldn?t think even.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Muscle spasms, Pain in extremity, Palpitations, Thirst
Clinical narrative: First night of secound dose. What light headed, disoriented. Walking into walls. Severely thirsty and nothing Quenched my thirst. Muscle spasms . Then after that migraines , brain fog . Then heart palpitations and sharp chest pain if tried exercise. Then upper outter leg pain . Both legs crying walking up steps . Then stomach issues and was hard to swallow water. Energy levels weee zero and couldn?t think even.
Age: 0.5
Sex: F
Vaccine: DTAPHEPBIP, PNC20
Symptoms: Infant irritability, Injection site induration
Clinical narrative: MOP stated that child had an induration on L leg and was fussy for a week.
Age: 79.0
Sex: F
Vaccine: PPV
Symptoms: Fatigue, Pyrexia
Clinical narrative: Fecer of 1 degree,  fatigue
Age: 32.0
Sex: F
Vaccine: RSV
Symptoms: Exposure during pregnancy, Extra dose administered, No adverse event
Clinical narrative: Patient is pregnant with EDD of 2/26/2025. She presented for a prenatal visit on 2/5/2025 and the provider CNM found the patient had two RSV injections. One was done on 1/3/25 and the other on 1/17/25. Patient didn't report any reaction.
Age: 9.0
Sex: F
Vaccine: HEP
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: NO ADVERSE REACTIONS/EVENT OCCURRED. I am reporting this for tracking of data from this safety event. Patient's forecast showed she was due for a Hep B vaccine. Verified patient's vaccine history and confirmed with provider patient needed a Hep B vaccine. Verified patient allergies, contraindications, medications list, vitals, and pertinent history. Order for Hep B Peds (Engerix/B) Ped/Adolescent was entered by provider. I verified the order. Hep B is not stocked in the Clinic records. I went to outpatient pharmacy with the patient's label and provided the patient's label to the pharmacist. I verbalized that I was from Clinic and needed a Hep B vaccine for this patient.  I was given the adult dose of Hep B vaccine (20 mcg) instead of the pediatric dose of Hep B vaccine (10 mcg). I did not know this was not the correct dose and I administered it to the patient. I went to document the vaccine that was given to provide an immunization record to the guardian but could not find the Lot# J3952 under the pediatric Hep B. I contacted outpatient pharmacy about this and was transferred to the point of contact pharmacist. I let her know I could not find the Lot# for the Hep B vaccine I picked up from the outpatient pharmacy. She assisted me in checking the Lot# and confirmed it was the Lot# for the adult Hep B vaccine.  This is when I realized the error. I had been given the adult dose of Hep B (20 mcg) instead of the pediatric dose (10 mcg), and I administered it, unaware this was the adult dose.
Age: 50.0
Sex: F
Vaccine: FLU3
Symptoms: Abdominal pain upper, Aphonia, Constipation, Diarrhoea, Dysphagia
Clinical narrative: An hour after the shot I felt extreme fatigue/ ?wiped out,? upon waking next morning severe aching pain stiffness and tingling in entire left arm, about 24 hours after, I felt like my throat closed up to half its usual width and got scratchy, food was catching, felt like a sinus infection was coming on. The next day my I lost my voice and only squeaks came out for the next 2.5 days. I had flu symptoms and missed two days of work. This segued into severe headache and upper respiratory congestion, stomach pains and nausea with diarrhea, mucous-covered stool and constipation. Two nosebleeds over this time.
Age: 50.0
Sex: F
Vaccine: FLU3
Symptoms: Epistaxis, Fatigue, Headache, Impaired work ability, Influenza
Clinical narrative: An hour after the shot I felt extreme fatigue/ ?wiped out,? upon waking next morning severe aching pain stiffness and tingling in entire left arm, about 24 hours after, I felt like my throat closed up to half its usual width and got scratchy, food was catching, felt like a sinus infection was coming on. The next day my I lost my voice and only squeaks came out for the next 2.5 days. I had flu symptoms and missed two days of work. This segued into severe headache and upper respiratory congestion, stomach pains and nausea with diarrhea, mucous-covered stool and constipation. Two nosebleeds over this time.